UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute myeloid leukaemia in adults

The Lancet (British edition), 2013-02, Vol.381 (9865), p.484-495

2013

Volltextzugriff (PDF)

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?

Haematologica (Roma), 2020-12, Vol.105 (12), p.2738-2745

2020

Volltextzugriff (PDF)

Discontinuation of tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia – You can do this at home if you read the instructions

Haematologica (Roma), 2019-08, Vol.104 (8), p.1508-1511

Schiffer, Charles A.

2019

Volltextzugriff (PDF)

Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1357-1370

2013

Volltextzugriff (PDF)

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

American journal of hematology, 2022-05, Vol.97 (5), p.514-518

2022

Volltextzugriff (PDF)

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3187-3205

2006

Volltextzugriff (PDF)

To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia

Haematologica (Roma), 2018-11, Vol.103 (11), p.1756-1757

2018

Volltextzugriff (PDF)

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

JNCI : Journal of the National Cancer Institute, 2016-07, Vol.108 (7), p.djw003

2016

Volltextzugriff (PDF)

Real‐world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis

Cancer, 2019-01, Vol.125 (1), p.135-143

2019

Volltextzugriff (PDF)

Glasdigib fails to slay the hedgehog in pivotal AML trials

Leukemia, 2023-12, Vol.37 (12), p.2520-2521

Schiffer, Charles A

2023

Volltextzugriff (PDF)

Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia

Haematologica (Roma), 2022-11, Vol.107 (11), p.2641-2649

2022

Volltextzugriff (PDF)

New patterns of genetic instability in chronic myelogenous leukemia: interesting, but not ready for clinical use

Haematologica (Roma), 2023-04

Schiffer, Charles A.

2023

Volltextzugriff (PDF)

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4642-4649

2003

Volltextzugriff (PDF)

Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50–54)

Transfusion (Philadelphia, Pa.), 2022-02, Vol.62 (2), p.267-272

Schiffer, Charles A.

2022

Volltextzugriff (PDF)

Asciminib for CML: same target, new arrow

Blood, 2021-11, Vol.138 (21), p.2009-2010

Schiffer, Charles A.

2021

Volltextzugriff (PDF)

Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AML

The New England journal of medicine, 2020-08, Vol.383 (7), p.677-679

Schiffer, Charles A

2020

Volltextzugriff (PDF)

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2429-2440

2002

Volltextzugriff (PDF)

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Blood advances, 2017-06, Vol.1 (15), p.1167-1180

2017

Volltextzugriff (PDF)

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5705-5717

2005

Volltextzugriff (PDF)

Optimal dose and schedule of consolidation in AML: Is there a standard?

Best practice & research. Clinical haematology, 2014-09, Vol.27 (3), p.259-264

Schiffer, Charles A., MD

2014

Volltextzugriff (PDF)

The evolution of dasatinib dosage over the years and its relevance to other anticancer medications

Cancer, 2018-07, Vol.124 (13), p.2687-2689

Schiffer, Charles A.

2018

Volltextzugriff (PDF)

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

BMC cancer, 2018-04, Vol.18 (1), p.359-359, Article 359

2018

Volltextzugriff (PDF)

“Epigenetic” modification as therapy for acute myeloid leukemia

Cancer, 2018-01, Vol.124 (2), p.242-244

Schiffer, Charles A.

2018

Volltextzugriff (PDF)

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2018-01, Vol.36 (3), p.283-299

2018

Volltextzugriff (PDF)

1 – 25 von 471

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(423)
Mit Volltextzugriff
(390)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(470)
Japanisch
(39)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(287)
Humans
(281)
Life Sciences & Biomedicine
(276)
Biological And Medical Sciences
(151)
Medical Sciences
(148)
Hematology
(143)
Male
(128)
Middle Aged
(126)
Female
(125)
Adult
(122)
Oncology
(111)
Aged
(99)
Pharmacology. Drug Treatments
(69)
Antineoplastic Agents
(62)
Hematologic And Hematopoietic Diseases
(62)
Chemotherapy
(60)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(57)
Treatment Outcome
(51)
Acute Disease
(46)
Adolescent
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute myeloid leukaemia in adults

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Discontinuation of tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia – You can do this at home if you read the instructions

Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

Real‐world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis

Glasdigib fails to slay the hedgehog in pivotal AML trials

Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia

New patterns of genetic instability in chronic myelogenous leukemia: interesting, but not ready for clinical use

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50–54)

Asciminib for CML: same target, new arrow

Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AML

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Optimal dose and schedule of consolidation in AML: Is there a standard?

The evolution of dasatinib dosage over the years and its relevance to other anticancer medications

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

“Epigenetic” modification as therapy for acute myeloid leukemia

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Suchergebnisse filtern